AUG 13, 2026 · JOURNAL ARTICLE
METTL3-mediated m6A modification of TP73-AS1 enhances HCC progression by activating Wnt/β-catenin signaling
Discover Oncology
A mechanistic study identifying a putative oncogenic pathway in HCC cell models, lacking clinical outcome data, human validation, or quantified effect sizes to support clinical translation.
Hypothesis-GeneratingWei ZhangCancer Related Molecular Mechanisms ResearchCancer, Hypoxia, and Metabolism